Clinical Trials on Patients Under Vitamin K Antagonist (VKA)
Total 6 results
-
University Hospital, GrenobleCompletedHealthy Volunteer | Patients Under Vitamin K Antagonist (VKA)France
-
MedicalpsIcadom; AG2R La Mondiale; AVALUN; ORIADE NOVIALE; SIL-LAB INNOVATIONS; TASDACompletedVitamine K Antagonist (VKA) Treatment | International Normalized Ratio (INR) Measure at Home | Thromboembolic PathologyFrance
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompleted
-
HealthPartners InstituteCompletedHemorrhage | Acute Bleeding on Long-Term Anticoagulation Therapy | Significant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time) | Urgent Reversal of Vitamin K Antagonist (VKA) AnticoagulationUnited States
-
Zhejiang UniversityShulan (Hangzhou) HospitalNot yet recruitingLiver Transplantation | Hepatocellular Carcinoma | Alpha-Fetoprotein | Protein Induced by Vitamin K Absence or Antagonist-II
-
Johannes Gutenberg University MainzSanofi; Bayer; Boehringer Ingelheim; German Federal Ministry of Education and Research and other collaboratorsCompletedAtrial Fibrillation | Venous Thromboembolism | Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic UseGermany